This page includes the latest FDA filings for New American Therapeutics. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2023-04-25 |
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2022-08-18 |
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2022-07-22 |
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2022-05-18 |
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2020-10-29 |
New American Therapeutics, ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY, AstraZeneca AB | Prescription Medication | 2020-09-03 |
New American Therapeutics | METOPROLOL SUCCINATE | 2020-08-31 |
New American Therapeutics | METOPROLOL SUCCINATE | 2020-08-31 |
New American Therapeutics | METOPROLOL SUCCINATE | 2020-08-31 |
New American Therapeutics | METOPROLOL SUCCINATE | 2018-01-01 |